Left atrial pressure monitoring in patients with a HeartMate II device using a Codman Microsensor

MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device

Hien Kiem Nguyen Thanh, MD, Jason Andrade, MD, Katia Dyrda, MD, MSc, PEng, Bernard Thibault, MD, FHRS, Paul Khairy, MD, Laurent Macle, MD, FHRS From the Electrophysiology Service, Montreal Heart Institute, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada, and Electrophysiology Service, Vancouver General Hospital, Department of Medicine, University of British Columbia, Va...

Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation

BACKGROUND AND PURPOSE It is unknown what the optimal anticoagulant level is to prevent thromboembolic stroke in patients with left ventricular assist device (LVAD) support. We aimed to evaluate the relation between coagulation status and the occurrence of thromboembolic stroke in HeartMate-II LVAD assisted patients. METHODS Thirty-eight consecutive patients with a HeartMate-II LVAD were incl...

Migration of a HeartMate II left ventricular assist device.

Evaluation of bend relief disconnection in patients supported by a HeartMate II left ventricular assist device.

L eft ventricular assist devices (LVADs) are an established treatment for patients with end-stage heart failure as either a bridge to cardiac transplantation 1 or as lifelong support, also known as destination therapy.) is a continuous flow device that was approved by the US Food and Drug Administration in 2008, after a pivotal trial in 133 patients awaiting transplantation. 3 More patients hav...

“Suction Event” in a Patient with a HeartMate II Left Ventricular Assist Device

Case Presentation: A 31 year old male with dilated cardiomyopathy and symptoms of New York Heart Association class IV heart failure presented for left ventricular assist device (LVAD) implantation as destination therapy. The patient was admitted to the hospital approximately one month prior with decompensation of his cardiomyopathy and associated liver failure. The patient was stabilized and wa...